Immunogenicity 15314
Sample ID
patient3
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ECI1
Transcript ID
None
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (285 aa)
MALVA
1
SVRVP
6
ARVLL
11
RAGAR
16
LPGAA
21
LGRTE
26
RAAGG
31
GDGAR
36
RFGSQ
41
RVLVE
46
PDAGA
51
GVAVM
56
KFKNP
61
PVNSL
66
SLEFL
71
TELVI
76
SLEKL
81
ENDKS
86
FRGVI
91
LTSDR
96
PGVFS
101
AGLDL
106
TEMCG
111
RSPAH
116
YAGYW
121
KAVQE
126
LWLRL
131
YQSNL
136
VLVSA
141
INGAC
146
PAGGC
151
LVALT
156
CDYRI
161
LADNP
166
RLKDT
171
LENTI
176
GHRAA
181
ERALQ
186
LGLLF
191
PPAEA
196
LQVGI
201
VDQVV
206
PEEQV
211
QSTAL
216
SAIAQ
221
WMAIP
226
DHARQ
231
LTKAM
236
MRKAT
241
ASRLV
246
TQRDA
251
DVQNF
256
VSFIS
261
KDSIQ
266
KSLQM
271
YLERL
276
KEEKG
281
Mutation Information
DNA mutation:
None
Peptide Range:
59 ~ 67
Mut AA position:
66 (8 in Wild Type peptide)
Alignment
Wild Type:
"VMKFKNPPV
|||||||.|
Mutant:
VMKFKNPLV"
Science, 2016
Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresGene Name (from Reference) DCI
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
MoDCs
Assay
IFNg ELISPOT assay